ACE2 and diabetes mellitus: The upregulation of ACE2 expression in DM cardiomyocytes, along with non-enzymatic glycation, could increase the susceptibility to COVID-19 infection in DM patients by favoring the cellular entry of SARS-CoV2, which lead to a worse prognosis (D’Onofrio et al., 2021).